Which blood tests should be ordered to screen for pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Tests for Pheochromocytoma Screening

Measure plasma free metanephrines (normetanephrine and metanephrine) or 24-hour urinary fractionated metanephrines as the initial screening test for pheochromocytoma. These tests have superior diagnostic accuracy compared to all other biochemical markers, with plasma free metanephrines demonstrating 99% sensitivity and urinary fractionated metanephrines showing 97% sensitivity 1.

Primary Screening Tests

The Endocrine Society strongly recommends one of two options 1:

  • Plasma free metanephrines (normetanephrine and metanephrine)
  • 24-hour urinary fractionated metanephrines (normetanephrine and metanephrine)

Both tests significantly outperform older markers including plasma catecholamines (84% sensitivity), urinary catecholamines (86% sensitivity), and urinary vanillylmandelic acid (64% sensitivity) 2.

Critical Sampling Requirements for Plasma Testing

If ordering plasma free metanephrines, the patient must be fully recumbent (lying flat) for at least 30 minutes before blood draw 1. This is non-negotiable for accurate results.

Why Positioning Matters

  • Seated blood sampling causes a 44% increase in plasma normetanephrine concentrations 3
  • This results in a 3.4-fold increase in false-positive results 3
  • Seated reference intervals are up to 2-fold higher than supine intervals, which can lead to a 3-fold increase in false-negative results if used incorrectly 1
  • Patients with pheochromocytoma do not show posture-related increases, so using seated reference ranges risks missing the diagnosis regardless of sampling position 1

Additional Preanalytical Factors

To minimize false positives for plasma testing 3:

  • Use intravenous cannula rather than direct venipuncture when possible
  • Conduct testing in warm conditions (cold temperatures increase false positives)
  • Outpatient sampling has 3.4-fold higher false-positive rates than inpatient sampling 3
  • If measuring 3-methoxytyramine (dopamine metabolite), collect after overnight fast 1

Choosing Between Plasma and Urine Tests

Plasma Free Metanephrines

Advantages:

  • Slightly higher sensitivity (99% vs 97%) 2
  • Higher specificity (89% vs 69%) 1
  • Single blood draw
  • Better for high-risk patients (familial syndromes, genetic mutations) 4

Disadvantages:

  • Requires strict collection protocol (30 minutes supine rest)
  • More false positives if collected incorrectly
  • Rarely implemented properly in routine practice 5

24-Hour Urinary Fractionated Metanephrines

Advantages:

  • Fewer false positives when plasma test done incorrectly
  • No special positioning requirements
  • More practical for mainstream clinical use 5
  • Must measure urinary creatinine simultaneously to verify complete collection 1

Disadvantages:

  • Requires complete 24-hour collection
  • Slightly lower specificity than properly collected plasma test

Laboratory Method Matters

Request liquid chromatography with mass spectrometry (LC-MS/MS) or electrochemical detection (LC-ECD) rather than immunoassay methods 1.

Immunoassays have demonstrated:

  • Lower diagnostic sensitivity 1
  • Substantial underestimation of metanephrine concentrations 1
  • False-negative results in confirmed pheochromocytoma cases 1

Interpreting Results

Positive Results

All positive results require appropriate follow-up 1. For borderline elevations:

  • Repeat sampling with strict supine positioning if initially done seated 1
  • Consider clonidine suppression test for persistent borderline normetanephrine elevation (97% sensitivity, 100% specificity, though not prospectively validated) 1
  • Rule out medication interference (tricyclic antidepressants, acetaminophen with certain assays) 1
  • Consider wait-and-retest approach (6+ months) in low-probability cases 1

Patterns Suggesting Pheochromocytoma

  • Noradrenergic secretion profile (elevated normetanephrine) strongly predicts symptomatic presentation 6
  • Extent and pattern of elevation can predict tumor size, location, and metastatic potential 5

Common Pitfalls to Avoid

  1. Seated blood sampling - This single error causes most false positives
  2. Using immunoassay methods - Inferior to LC-MS/MS or LC-ECD
  3. Incomplete 24-hour urine collection - Always verify with creatinine measurement
  4. Testing during acute illness - Physiological stress in ICU settings causes false positives 1
  5. Ignoring medication interference - Review all medications before testing
  6. Using seated reference intervals for supine samples - Leads to false negatives

Clinical Context

Recent evidence shows plasma and urine metanephrines correlate significantly and can be used interchangeably, with urinary fractionated metanephrine showing 90% sensitivity and plasma free metanephrines 84% sensitivity in surgical cohorts 7. Given the practical challenges of proper plasma collection in most clinical settings, 24-hour urinary fractionated metanephrines represent the most reliable first-line test for routine practice 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.